Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)

Market Cap	21.46B -22.6%
Revenue (ttm)	8.55B -9.2%
Net Income	373.17M -67.4%
EPS	0.25 -68.5%
Shares Out	1.49B
PE Ratio	57.89
Forward PE	19.46
Dividend	0.10 (0.68%)
Ex-Dividend Date	Jun 18, 2026

Volume	12,516,876
Open	14.44
Previous Close	14.40
Day's Range	14.05 - 14.59
52-Week Range	13.73 - 27.97
Beta	0.16
Analysts	Hold
Price Target	17.70 (+21.65%)
Earnings Date	Aug 27, 2026

About SHA:600521

Zhejiang Huahai Pharmaceutical Co., Ltd. engaged in the research, development, production and sales of generic drugs, biological drugs, and APIs in multiple dosage forms in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as polyethylene bottles and polypropylene caps for pharmaceuticals. In addition, the company offers contract manufacturing and other services, as well as import and export trade serv...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1989
• Employees: 8,797
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600521

Financial Performance

In 2025, SHA:600521's revenue was 8.59 billion, a decrease of -10.06% compared to the previous year's 9.55 billion. Earnings were 266.40 million, a decrease of -76.19%.

Analyst Summary

According to 3 analysts, the average rating for 600521 stock is "Hold." The 12-month stock price target is ¥17.70, which is an increase of 21.65% from the latest price.

Price Target

¥17.70

(21.65% upside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 1, 2026

Data Sources Report a data error